ASXL1 mutations in idiopathic cytopenias: determined significance?

Carlos Galvez; Brady L. Stein

doi:10.1080/10428194.2018.1516880

ASXL1 mutations in idiopathic cytopenias: determined significance?

Carlos Galvez, Brady L. Stein^*

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	568-570
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	60
Issue number	3
DOIs	https://doi.org/10.1080/10428194.2018.1516880
State	Published - Feb 23 2019

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2018.1516880

Cite this

@article{952aa767231a4cf2b61a6d0569319d93,

title = "ASXL1 mutations in idiopathic cytopenias: determined significance?",

author = "Carlos Galvez and Stein, {Brady L.}",

year = "2019",

month = feb,

day = "23",

doi = "10.1080/10428194.2018.1516880",

language = "English (US)",

volume = "60",

pages = "568--570",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - ASXL1 mutations in idiopathic cytopenias

T2 - determined significance?

AU - Galvez, Carlos

AU - Stein, Brady L.

PY - 2019/2/23

Y1 - 2019/2/23

UR - http://www.scopus.com/inward/record.url?scp=85054353814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054353814&partnerID=8YFLogxK

U2 - 10.1080/10428194.2018.1516880

DO - 10.1080/10428194.2018.1516880

M3 - Comment/debate

C2 - 30277129

AN - SCOPUS:85054353814

SN - 1042-8194

VL - 60

SP - 568

EP - 570

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 3

ER -

ASXL1 mutations in idiopathic cytopenias: determined significance?

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this